The Ainslie Lab has a new publication in collaboration with Dr. Mireia Guerau-de-Arellano at Ohio State. Mirea’s lab identified PRMT’s potential role as a therapy-target for the treatment of multiple sclerosis and perhaps other autoimmune diseases. Also, the beautiful docking graphic of a small molecule inhibitor in PRMT, done by Dr. Chenlong Li, was featured on the cover of JI!
http://www.jimmunol.org/conte…/…/2017/01/12/jimmunol.1601702
